Lauren P. Silvernail, CFO, CBO & Secretary at Revance Therapeutics, Inc. (RVNC), sold 6,862 shares at $30.85 ($212K) on 2018-03-22, disclosed to the SEC on 2018-03-23.
Open-market sale of $212k RVNC by CFO, CBO & Secretary. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $30.85 | 3,431 | $106K | 50.0% |
| 2 | $30.85 | 3,431 | $106K | 50.0% |
| Total | $30.85 avg | 6,862 | $212K | 100% |
| Filing → |
| EOLS | SELL | 2022-03-10 | $198K | — | Filing → |
| EOLS | SELL | 2021-08-12 | $320K | — | Filing → |
| EOLS | SELL | 2021-01-26 | $20K | — | Filing → |